LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...
Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...
NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ — Ningbo Qinmeng Maternal and Child Products Co., Ltd., a subsidiary of Ningbo Ciliang Import and ...
Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...
A Critical Step in Hepatitis B Diagnosis and Prevention in Canada bioLytical’s iStatis Hepatitis Surface Antigen Test (iStatis HBsAg Test) has ...
Point-of-care testing identifies ARDS inflammatory subphenotypes in real time, offering insights into patient prognosis and mortality risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results